BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Implant Sciences Corporation (IMX) Discusses Recent Sale of the Company's Common Stock by CorNova


3/8/2007 1:17:29 PM

WAKEFIELD, Mass.--(BUSINESS WIRE)--Implant Sciences Corporation (AMEX: IMX) a developer and manufacturer of products for national security, semiconductor and medical industries, announced today its understanding that CorNova Inc. (“CorNova”), a privately-held company focused on the development and marketing of innovative endovascular diagnostics and treatments, has sold approximately 75,000 shares of Implant’s common stock over the past two (2) days through its broker. In March 2004 and February 2005, CorNova acquired approximately 87,000 shares, in the aggregate, of Implant’s common stock in connection with (i) the capitalization of CorNova in March 2004 and (ii) the successful completion of a financing by CorNova in February 2005. The Company understands that the liquidation of Implant’s common stock by CorNova is to provide funding for CorNova’s working capital. CorNova continues to hold approximately 12,000 shares of Implant’s common stock, whose disposition we believe is imminent.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES